The World Needs New Antibiotics. The Problem Is, No One Can Make Them Profitably.

Dominique Mosbergen

September 29, 2023

The push for antibiotics to fight fast-evolving superbugs is snagging on a broken business model.

Six startups have won Food and Drug Administration approval for new antibiotics since 2017. All have filed for bankruptcy, been acquired or are shutting down. About 80% of the 300 scientists who worked at the companies have abandoned antibiotic development, according to Kevin Outterson, executive director of CARB-X, a government-funded group promoting research in the field…

Read the article in Wall Street Journal.

Off Script: A Pharma Manufacturing Podcast

Antibiotic resistance crisis and the global efforts against superbugs

Join senior editor Andrea Corona and Emily Wheeler, Director of Infectious Disease Policy at the Biotechnology Innovation Organization (BIO), as…

Putting a face on the ‘invisible threat’ of antimicrobial resistance

Mallory Smith was a young woman who, in her own words, had "big dreams and big goals." When she was…

How the pandemic gave power to superbugs

Antibiotics cannot cure COVID. They don’t help a bit. And yet, new data shows that, during the pandemic, COVID patients…

Fighting AMR with a value and subscription model

The recent reintroduction of the Pasteur Bill seeks to address the global threat that antimicrobial-resistant (AMR) infections pose, one subscription…

Name
First Last
Email
Zipcode
Organization
Title
Phone
This field is for validation purposes and should be left unchanged.

Wall Street Journal

The World Needs New Antibiotics. The Problem Is, No One Can Make Them Profitably.

Dominique Mosbergen

September 29, 2023

More

Off Script: A Pharma Manufacturing Podcast

Antibiotic resistance crisis and the global efforts against superbugs

CIDRAP

Putting a face on the ‘invisible threat’ of antimicrobial resistance

NPR

How the pandemic gave power to superbugs

Pharmaceutical Technology

Fighting AMR with a value and subscription model

Sign up for the latest on fighting AMR